CINECA IRIS Institutional Research Information System

D'ALESSANDRO, MIRIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 455
AS - Asia 332
EU - Europa 256
SA - Sud America 35
AF - Africa 11
OC - Oceania 3
Totale 1.092
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 439
IT - Italia 125
CN - Cina 87
SG - Singapore 84
HK - Hong Kong 80
FR - Francia 46
VN - Vietnam 37
DE - Germania 32
BR - Brasile 25
PL - Polonia 18
BD - Bangladesh 9
MX - Messico 8
GB - Regno Unito 7
CA - Canada 6
NL - Olanda 6
IN - India 5
AR - Argentina 4
ES - Italia 4
ID - Indonesia 4
AU - Australia 3
BE - Belgio 3
KR - Corea 3
SA - Arabia Saudita 3
TR - Turchia 3
AZ - Azerbaigian 2
BG - Bulgaria 2
CO - Colombia 2
DZ - Algeria 2
EC - Ecuador 2
IQ - Iraq 2
JP - Giappone 2
KE - Kenya 2
KZ - Kazakistan 2
MA - Marocco 2
RS - Serbia 2
UA - Ucraina 2
ZA - Sudafrica 2
AT - Austria 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
CY - Cipro 1
CZ - Repubblica Ceca 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IE - Irlanda 1
KH - Cambogia 1
LT - Lituania 1
MG - Madagascar 1
MN - Mongolia 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
QA - Qatar 1
TH - Thailandia 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 1.092
Salva come PNG Salva come JPEG
Città #
San Jose 171
New York 105
Hong Kong 80
Ashburn 56
Beijing 49
Singapore 41
Frankfurt am Main 27
Hillsboro 17
Naples 14
Warsaw 13
Vigonza 11
Hanoi 10
Ho Chi Minh City 10
Rome 10
Los Angeles 9
Milan 9
Rimini 8
Mexico City 6
Buffalo 5
Bologna 4
Florence 4
Montreal 4
San Mauro Pascoli 4
Turin 4
Charlotte 3
Council Bluffs 3
Da Nang 3
Dallas 3
Orem 3
Reston 3
Riyadh 3
Santa Clara 3
Seoul 3
Thái Nguyên 3
Wroclaw 3
Amsterdam 2
Baghdad 2
Brussels 2
Cagliari 2
Catania 2
Cerdanyola del Vallès 2
Chennai 2
Chicago 2
City of London 2
Guayaquil 2
Hackney 2
Jakarta 2
Limburg an der Lahn 2
Madrid 2
Mumbai 2
Padua 2
Palermo 2
Pisa 2
Ravenna 2
Shenzhen 2
Sorocaba 2
Sydney 2
São João de Meriti 2
Abidjan 1
Acapulco de Juárez 1
Adelaide 1
Agadir 1
Alleur 1
Alliston 1
Amadora 1
Ancona 1
Annandale 1
Antananarivo 1
Astana 1
Aversa 1
Avşar 1
Baku 1
Bamberg 1
Baranello 1
Bari 1
Batanovtsi 1
Baton Rouge 1
Belgrade 1
Belo Horizonte 1
Belém 1
Bexley 1
Blagoevgrad 1
Bogotá 1
Bolton 1
Brescia 1
Buriticupu 1
Cambé 1
Caxias do Sul 1
Cazin 1
Constantine 1
Curitiba 1
Dhaka 1
Diadema 1
Doha 1
Dom Pedrito 1
Dublin 1
Eldorado do Sul 1
Florianópolis 1
Georgetown 1
Gricignano di Aversa 1
Totale 792
Salva come PNG Salva come JPEG
Nome #
Evaluation of short and long-term laboratory and instrumental findings in COVID-19 patients hospitalized in Tuscany 37
Retrospective Study on the Features and Outcomes of a Tuscany COVID-19 Hospitalized Patients Cohort: Preliminary Results 34
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 18
From Prognostic Marker to Therapeutic Agent: The Role of Nitric Oxide in Lung Cancer 16
BAL Proteomic Signature of Lung Adenocarcinoma in IPF Patients and Its Transposition in Serum Samples for Less Invasive Diagnostic Procedures 15
Peripheral biomarkers' panel for severe COVID-19 patients 15
Real-life comparison between pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis 15
Adding pieces to the puzzle: IL-33 contribution to fibrogenesis in chronic lung allograft dysfunction 14
Altered serum concentrations of IL-8, IL-32 and IL-10 in patients with lung impairment 6 months after COVID-19 13
AB0611 Neutrophil extracellular traps and interstitial lung disease in ANCA-associated vasculitis: a scoping review 13
POS0823 KL-6 IN ANCA-ASSOCIATED VASCULITIS PATIENTS WITH AND WITHOUT ILD: A MACHINE LEARNING APPROACH 13
Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis 13
Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies 13
A Comprehensive Review of Sarcoidosis Diagnosis and Monitoring for the Pulmonologist 12
Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy 12
A Novel Ultrasonographic Anthropometric-Independent Measurement of Median Nerve Swelling in Carpal Tunnel Syndrome: The "Nerve/Tendon Ratio" (NTR) 12
A multicenter study of extracellular vesicles profile in bronchoalveolar lavage from patients affected by IPF, HP and sarcoidosis 12
Alteration of Immune-checkpoint after specific stimulation with CMV antigens in pre-LTx patients 12
Serial autoantibody detection in interstitial lung diseases: should they be repeated at follow-up? 12
Alveolar nitric oxide as a biomarker of COVID-19 lung sequelae: A pivotal study 11
Accuracy of power Doppler ultrasonography in the diagnosis and monitoring of idiopathic inflammatory myopathies 11
A real-life experience with ImmunoCAP ISAC: the advantages of a new diagnostic method 11
Adaptive immune system in pulmonary sarcoidosis - comparison of peripheral and alveolar biomarkers 11
An explainable model of host genetic interactions linked to COVID-19 severity 11
Comparative Serum Protein Profiles in IPF Patients Before and After Nintedanib Therapy 11
Neutrophil-to-lymphocyte ratio in IPF patients: a novel prognostic biomarker? 11
A Precision Surgery Framework for Lung Resection: Robotic, Video-Assisted, and Open Segmentectomy 11
Immune-Checkpoint expression on CD4, CD8 and NK cells in blood, BAL and lymph nodes of sarcoidosis 10
POS0871 diagnostic accuracy og power doppler ultrasonography for the diagnosis of idiopathic inflammmatory myopathies 10
Adiponectin and leptin levels in idiopathic pulmonary fibrosis: A new method for BAL and serum assessment 10
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 10
Alveolar nitric oxide is related to periostin levels in idiopathic pulmonary fibrosis 10
A Comprehensive Evaluation of Mepolizumab Effectiveness in a Real-Life Setting 10
Relapses of idiopathic inflammatory myopathies after vaccination against COVID19: a real-life Italian study 10
Adhesion molecules and T cell imbalance in severe eosinophilic asthma: Insights from anti-IL-5R treatment 10
Extracellular Vesicle Surface Signatures in IPF Patients: A Multiplex Bead-Based Flow Cytometry Approach 10
Anti-Cytosolic 5′-Nucleotidase 1A in the Diagnosis of Patients with Suspected Idiopathic Inflammatory Myopathies: An Italian Real-Life, Single-Centre Retrospective Study 10
Systematic review and metanalysis of oncomarkers in ipf patients and serial changes of oncomarkers in a prospective italian real-life case series 10
A multicenter approach to evaluate omalizumab effectiveness in Samter’s triad 9
PD-1/TIGIT axis: a novel therapeutic target? 9
Strain echocardiography is a promising tool for the prognostic assessment of sarcoidosis 9
A first update on mapping the human genetic architecture of COVID-19 9
The Effects of Interstitial Lung Diseases on Alveolar Extracellular Vesicles Profile: A Multicenter Study 9
Benralizumab affects NK cell maturation and proliferation in severe asthmatic patients 9
Safety and uptake of solid lipid nanoparticles by airway epithelial cells: an in vitro study 9
Evaluation of multiple-flows exhaled nitric oxide and its clinical significance in severe asthmatic patients treated with biologics: a prospective real-life study 9
BAL and serum multiplex lipid profiling in idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis 9
Mepolizumab and Benralizumab in Severe Eosinophilic Asthma: Preliminary Results of a Proteomic Study 9
Multiple-flows exhaled nitric oxide for the detection and severity assessment of post-COVID19 lung sequelae 8
Serum CD59: a novel biomarker of idiopathic pulmonary fibrosis? 8
Ceruloplasmin and oxidative stress in severe eosinophilic asthma patients treated with Mepolizumab and Benralizumab 8
The effectiveness of nintedanib in patients with idiopathic pulmonary fibrosis, familial pulmonary fibrosis and progressive fibrosing interstitial lung diseases: a real-world study 8
Valutazione prognostica della Siero Amiloide A in pazienti affetti da Fibrosi Polmonare Idiopatica 8
Natural killer T-cells in asthma pathogenesis and treatment: old problems and future perspectives 8
Prognostic evaluation of alveolar concentration of nitric oxide, serum periostin and CD59 in patients with idiopathic pulmonary fibrosis 8
Immunological Similarities and Differences between Post-COVID-19 Lung Sequelae and Idiopathic Pulmonary Fibrosis 8
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 8
Effects of rituximab therapy on B cell differentiation and depletion 8
Pleuroparenchymal fibroelastosis in interstitial lung disease with antineutrophil cytoplasmic antibody-associated vasculitis 8
Proteomic Analysis of Serum from Severe Asthma Patients Before and After Mepolizumab and Benralizumab Treatment 8
The value of urinary calcium as biomarker in chronic sarcoidosis 8
Extracellular Vesicles in Pulmonary Fibrosis Models and Biological Fluids of Interstitial Lung Disease Patients: A Scoping Review 8
Fibroblast-like culture from bronchoalveolar lavage of patient with idiopathic pulmonary fibrosis 8
Mapping the human genetic architecture of COVID-19 7
BAL as a research tool 7
Regulatory and Effector Cell Disequilibrium in Patients with Acute Cellular Rejection and Chronic Lung Allograft Dysfunction after Lung Transplantation: Comparison of Peripheral and Alveolar Distribution 7
Follicular T helper and Breg cell balance in severe allergic asthma before and after omalizumab therapy 7
Serum concentrations of KL-6 in patients with IPF and lung cancer and serial measurements of KL-6 in IPF patients treated with antifibrotic therapy 7
Regulatory T Cell Phenotype Related to Cytokine Expression Patterns in Post-COVID-19 Pulmonary Fibrosis and Idiopathic Pulmonary Fibrosis 7
Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients 7
Combined Sarcoidosis and Idiopathic Pulmonary Fibrosis (CSIPF): A New Phenotype or a Fortuitous Overlap? Scoping Review and Case Series 7
NK and T cell in patients with end-stage lung disorders waiting for lung transplantation in response to CMV infection 7
Strain echocardiography for the prognostic estimation of patients with sarcoidosis 7
NK cell maturation and proliferation in severe asthmatic patients after Benralizumab therapy 7
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis 7
Online survey on existing sarcoidosis registries and biobanks: An ERN lung initiative 7
Regulatory T cells and L-selectin in severe asthmatic patients treated with mepolizumab 7
The impact of anti-IL5 therapies on patients with severe eosinophilic asthma: a proteomic approach 7
Clinical and molecular characterization of COVID-19 hospitalized patients 7
Real-life experience of severe asthma patients on Dupilumab treatment in Pordenone’s Hospital 7
The role of calcium metabolism assessment in the clinical setting of interstitial lung diseases 7
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 7
NK and T cells responses to CMV in patients awaiting for lung transplantation 7
Evaluation of bone mineral density and fracture risk in sarcoidosis population 7
Bronchoalveolar-Lavage-Derived Fibroblast Cell Line (B-LSDM7) as a new protocol for investigating the mechanisms of idiopathic pulmonary fibrosis 7
Interpretation and clinical significance of multiple-flows exhaled nitric oxide in severe asthma framework 6
The role of the combination of echo-HRCT score as a tool to evaluate the presence of pulmonary hypertension in idiopathic pulmonary fibrosis 6
Long-Term Follow-Up of Patients With Idiopathic Pulmonary Fibrosis Treated With Pirfenidone or Nintedanib: A Real-Life Comparison Study 6
Nk and t cell immunological signatures in hospitalized patients with covid-19 6
Diagnostic Value of Krebs von den Lungen (KL-6) for Interstitial Lung Disease: A European Prospective Cohort 6
Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review 6
Evaluation of treatment with Nintedanib in patients with idiopathic pulmonary fibrosis: a proteomical approach 6
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 6
Whole-genome sequencing reveals host factors underlying critical COVID-19 6
WES profiling of COVID-19 6
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 6
Prognostic role of KL-6 in SSc-ILD patients with pleuroparenchymal fibroelastosis 6
T helper and T cytotoxic cells subsets in peripheral, alveolar and lymph nodes of sarcoidosis patients 6
Combined use of serum KL-6 and respiratory functional parameters for identifying fibrotic lung damage in SARS-CoV-2-induced interstitial pneumonia 6
Interleukin-6 and krebs von den lungen-6 in lymphangioleiomyomatosis patients 6
Totale 953
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.621
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.621
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202513 0 0 0 0 0 0 0 0 3 8 2 0
2025/20261.319 9 3 11 14 5 1 93 465 284 434 0 0
Totale 1.332